Wall Street brokerages predict that Aptevo Therapeutics Inc (NASDAQ:APVO) will post sales of $6.87 million for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Aptevo Therapeutics’ earnings. The highest sales estimate is $6.89 million and the lowest is $6.85 million. Aptevo Therapeutics reported sales of $6.17 million in the same […]
